3',4',5'-trimethylacetanilide | 1467-34-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3',4',5'-trimethylacetanilide
• 英文别名: acetic acid-(3,4,5-trimethyl-anilide)；Essigsaeure-(3,4,5-trimethyl-anilid)；3,4,5-trimethylacetanilide；1,2,3-Trimethyl-5-acetamidobenzol；3,4,5-Trimethyl-acetanilid；N-(3,4,5-Trimethylphenyl)acetamide
• CAS: 1467-34-1
• 化学式: C₁₁H₁₅NO
• 分子量: 177.246
• InChiKey: AYPHGQFINZMFCT-UHFFFAOYSA-N

物化性质

• 熔点：
  166 °C
• 沸点：
  322.2±11.0 °C(Predicted)
• 密度：
  1.034±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3',4',5'-trimethylacetanilide 在 盐酸 作用下， 生成 3,4,5-三甲基苯胺
  参考文献：
  名称：

  Buu-Hoi,N.P. et al., Bulletin de la Societe Chimique de France, 1965, p. 322 - 326

  摘要：

  DOI：
• 作为产物：
  描述：

  1-(3,4,5-trimethyl-phenyl)-ethanone oxime 在 五氯化磷 作用下， 以 乙醚 为溶剂， 反应 0.5h， 生成 3',4',5'-trimethylacetanilide
  参考文献：
  名称：

  Buu-Hoi,N.P. et al., Bulletin de la Societe Chimique de France, 1965, p. 322 - 326

  摘要：

  DOI：

文献信息

• Herbicidal cyclohexane-1,3-dione derivatives
  申请人：ICI Australia Limited

  公开号：US04640708A1

  公开（公告）日：1987-02-03

  Compounds of the formula ##STR1## wherein: R.sup.5 is a bicyclic aryl or nitrogen-containing heteroaryl ring system such as naphthyl, quinolyl, isoquinolyl or tetrahydroisoquinolyl, optionally substituted by a wide variety of groups; R.sup.4 and R.sup.1 are preferably hydrogen but may be other groups and R.sup.2 and R.sup.3 are selected from alkyl, haloalkyl, alkenyl, haloalkenyl and alkynyl, show high general grass-killing activity with good selectivity to many broad-leaf crops and in some instances selectivity to small-grain cereals. Processes for the preparation of compounds of formula I, intermediates in the preparation of compounds I and the herbicidal properties of compounds I are described.

  公式为##STR1##的化合物，其中：R.sup.5是双环芳基或含氮杂芳基环系统，如萘基、喹啉基、异喹啉基或四氢异喹啉基，可选择性地被各种基团取代；R.sup.4和R.sup.1最好是氢，但也可以是其他基团，R.sup.2和R.sup.3选自烷基、卤代烷基、烯基、卤代烯基和炔基，在对许多广叶作物具有高度杀草活性的同时，对一些小粒谷物具有良好的选择性。描述了制备公式I化合物的方法，制备公式I化合物的中间体以及公式I化合物的除草性能。
• DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS
  申请人：Matsuyama Hironori

  公开号：US20100004438A1

  公开（公告）日：2010-01-07

  An object of the present invention is to provide a medicinal drug much improved in anti tumor activity and excellent in safety. According to the present invention, there is provided a medicinal drug containing a compound represented by the following general formula (1) or a salt thereof as an active ingredient: [Formula 1] wherein X 1 represents a nitrogen atom or a group —CH═, R 1 represents a group -Z-R 6 , in which Z represents a group —CO—, a group —CH(OH)— or the like, R 6 represents a 5- to 15-membered monocyclic, dicyclic or tricyclic saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms, R 2 represents a hydrogen atom or a halogen atom, Y represents a group —O—, a group —CO—, a group —CH(OH)— or a lower alkylene group, and A represents [Formula 2] wherein R 3 represents a hydrogen atom, a lower alkoxy group or the like, p represents 1 or 2, R 4 represents an imidazolyl lower alkyl group or the like.

  本发明的一个目的是提供一种在抗肿瘤活性方面大大改进且安全性优异的药物。根据本发明，提供了一种包含以下一般式（1）所表示的化合物或其盐作为活性成分的药物：[式1]其中X1代表氮原子或基团—CH═，R1代表一个基团-Z-R6，其中Z代表基团—CO—，基团—CH(OH)—或类似的基团，R6代表一个含有1至4个氮原子、氧原子或硫原子的5至15个成员的单环、双环或三环饱和或不饱和杂环基团，R2代表氢原子或卤原子，Y代表基团—O—，基团—CO—，基团—CH(OH)—或低碳烷基基团，A代表[式2]其中R3代表氢原子、低碳氧基基团或类似基团，p代表1或2，R4代表咪唑基低碳基团或类似基团。
• Nitration studies of 4-substituted toluenes, 5-substituted hemimellitenes and acetoxyprehnitene
  作者：AH Clemens、MP Hartshorn、KE Richards、GJ Wright

  DOI：10.1071/ch9770113

  日期：——

  Product distributions are reported for the nitration of 4-methoxy-, 4- bromo- and 4-acetoxy-toluenes, of 5-fluoro- and 5-acetamido- hemimellitenes, and of acetoxyprehnitene. A Hammett p value for ipso nitration is estimated from competitive nitrations with a series of 5-substituted hemimellitenes.

  报告了 报告了 4-甲氧基甲苯、4-溴甲苯和 4-乙酰氧基甲苯、5-氟甲苯和 5-乙酰氨基半甲苯以及乙酰氧基苯乙烯的硝化产物分布。 5-氟和 5-乙酰氨基半亚甲基苯，以及乙酰氧基麻黄烯的硝化产物分布。同位硝化的 Hammett 同位硝化的 p 值是通过与一系列 5-取代半亚甲基苯的竞争性硝化来估算的。 一系列 5-取代半亚甲基苯的竞争性硝化反应估算出同位硝化的 Hammett p 值。
• Aromatic Compounds
  申请人：Fukushima Tae

  公开号：US20070270422A1

  公开（公告）日：2007-11-22

  The present invention provides a novel compound, which has an excellent effect of suppressing the generation of collagen and less side effects, with being excellent in terms of safety. The compound of the present invention is represented by the following general formula (1): [wherein X 1 represents a nitrogen atom or a group —CH═; R 1 represents a group -Z-R 6 , wherein Z represents a group —CO—, a group —CH(OH)—, or the like, and R 6 represents a 5- to 15-membered monocyclic, dicyclic, or tricyclic, saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms, or sulfur atoms; R 2 represents a hydrogen atom, a halogen atom or a lower alkylene group; Y represents a group —O—, a group —CO—, a group —CH(OH)—, a lower alkylene group, or the like; and A represents a group or the like, wherein R 3 represents a hydrogen atom, a lower alkoxy group, or the like, p represents 1 or 2, and R 4 represents an imidazolyl lower alkyl group or the like.

  本发明提供了一种新型化合物，具有抑制胶原生成的优异效果，并且具有较少的副作用，在安全性方面表现出色。本发明的化合物由以下通式（1）表示：[其中X1代表氮原子或基团—CH═；R1代表基团-Z-R6，其中Z代表基团—CO—、基团—CH(OH)—或类似基团，而R6代表具有1到4个氮原子、氧原子或硫原子的5-到15元的单环、双环或三环、饱和或不饱和杂环基团；R2代表氢原子、卤素原子或低碳链基团；Y代表基团—O—、基团—CO—、基团—CH(OH)—、低碳链基团或类似基团；A代表基团或类似基团，其中R3代表氢原子、低碳醚基团或类似基团，p代表1或2，而R4代表咪唑基低碳基团或类似基团。
• HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF
  申请人：Sumida Takumi

  公开号：US20100261720A1

  公开（公告）日：2010-10-14

  The present invention provides a heterocyclic compound represented by General Formula (1): wherein R 1 is a group R 5 —Z 1 —, etc., Z 1 is a lower alkylene group, etc., and R 5 is a group represented by General Formula; wherein R 13 is a hydrogen atom, etc., m is an integer from 1 to 5; R 2 is a hydrogen atom: Y is CH or N: A 1 is a heterocyclic ring selected from the group consisting of indolediyl groups, wherein the heterocyclic ring may have at least one substituent: T is a group —CO—, etc.: R 3 is a hydrogen atom, etc.: R 4 is a lower alkyl group optionally substituted by one or more hydroxy groups, etc.: R 3 and R 4 , together with the nitrogen atom to which they bind, may bind to each other and form a 5- to 10-membered saturated heterocyclic ring, wherein the heterocyclic ring may have at least one substituent. The heterocyclic compound of the present invention has excellent effects of suppressing the production of collagen and/or treating tumors.

  本发明提供一种由通式(1)表示的杂环化合物：其中R1为R5-Z1-等基团，Z1为低碳烷基等，而R5则为通式所表示的基团；其中R13为氢原子等，m为1到5的整数；R2为氢原子；Y为CH或N；A1为选自吲哚二基基团等的杂环环；其中该杂环环可以具有至少一个取代基；T为-CO-等基团；R3为氢原子等；R4为低碳基基团，可以选择性地被一个或多个羟基取代等；R3和R4与它们所结合的氮原子一起可以结合成一个5-到10-成员的饱和杂环环，其中该杂环环可以具有至少一个取代基。本发明的杂环化合物具有抑制胶原蛋白产生和/或治疗肿瘤的优异效果。